UC cardiologist finds proteins in diabetic patients may indicate future heart disease

“I was down for about 20 minutes and they defibrillated me twice on site, possibly three times,” she says. “Obviously, I was unaware of it. I know from reading the reports what happened.”

“I was extremely fortunate that someone found me within seconds of collapsing,” says Riesenberg. “Had it happened anywhere else I wouldn’t be talking to you right now. If I had been in the basement doing laundry, I would have been in trouble.”

The 51-year-old Loveland, Ohio, resident was transported to UC Health’s West Chester Hospital where she learned she was a Type 2 diabetic and had suffered previous damage to the heart that led to a big blockage of her left coronary artery while at the amusement park. That type of blockage is often referred to as the “widow maker.”

Donald Lynch Jr., MD, assistant professor at the University of Cincinnati College of Medicine and UC Health cardiologist, says that the link between diabetes and heart disease often leads to adverse health outcomes for patients. Approximately 65% of deaths among patients with diabetes are due to cardiovascular disease.

Lynch, also Riesenberg’s current cardiologist, will be presenting preliminary research virtually at the American College of Cardiology on Saturday, May 15, that suggests plasma proteins discovered in the blood samples of diabetic patients who went on to develop obstructive coronary disease (OCAD) may serve as biomarkers of severe heart blockage. The findings might benefit patients like Riesenberg in the future.

Riesenberg says an internal defibrillator was implanted in her heart after her heart attack.

“There was no explanation why I survived the first heart attack or second heart attack. They also diagnosed me as diabetic that day. Mind you, I should have known. I had been a gestational diabetic, and I had been overweight, but I thought I was doing all the right things.

“We took samples of plasma and used mass spectrometry to see if we could find biomarkers that were predictive of patients developing obstructive coronary disease,” says Lynch. “The significance of this is I see patients who have diabetes and unfortunately develop blockages but no symptoms.”

Lynch says Riesenberg was fortunate that she survived her heart attack and cardiac arrest. “For many patients that’s not the case,” he says. “We know patients with diabetes are much more likely to have blockages in the heart and unfortunately they are more likely to be asymptomatic which places them at significant risk. We don’t have good tools to figure out which patients will develop blockages.”

“What we found is that we can use a blood test and identify patients with diabetes who might develop obstructive coronary disease,” says Lynch. “It is a challenge to identify which patients with diabetes are at higher risk. This may be a good tool in our toolbox to help us in our fight against cardiovascular disease in patients with diabetes.”

“We can get them to a provider and have them assessed early for the possibility of developing obstructive coronary disease,” says Lynch.

The research is particularly important to Lynch, who disclosed he also battles diabetes. He has planned future studies to further evaluate the ability of these biomarkers to identify patients with coronary disease and improve cardiac outcomes for patients with diabetes. 

The preliminary research has definitely captured the interest of Riesenberg, who spoke with Lynch about his findings.

“It fascinates me that a simple blood test might be able to tell my children that this is on their horizon, and you don’t have to be dependent on a cardiac device for the rest of your life,” says Riesenberg.

Other research co-authors from UC include David Hui, PhD, professor of pathology and laboratory medicine along with Auriela Howze, a UC undergraduate majoring in chemistry. Additional co-authors include Koen Raedschelders, PhD, Jennifer Van Eyk, PhD, and Mitra Mastali, PhD, all of Cedars-Sinai Medical Center, Los Angeles and James Januzzi, MD, of Massachusetts General Hospital, Boston. 

Funding for the research is from Cedars-Sinai Advanced Clinical Biosystems Research Institute, University of Cincinnati College of Medicine Department of Internal Medicine Rehn Family Research Award. 

Featured image at top: Donald Lynch, Jr., MD. Photo/Colleen Kelley/UC Creative + Brand.